Cargando…

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients

BACKGROUND: Induction therapy is crucial in kidney transplantation and constitutes an important cornerstone for long-term allograft survival. Alemtuzumab is a depleting CD52-specific antibody with T- and B-cell activity, leading to prolonged lymphocyte depletion for up to 12 months, with profound im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guthoff, Martina, Berger, Kilian, Althaus, Karina, Mühlbacher, Thomas, Bakchoul, Tamam, Steurer, Wolfgang, Nadalin, Silvio, Königsrainer, Alfred, Heyne, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218828/ https://www.ncbi.nlm.nih.gov/pubmed/32404066 http://dx.doi.org/10.1186/s12882-020-01767-z

Ejemplares similares

Standardized, risk-adapted induction therapy in kidney transplantation
por: Eisinger, Felix, et al.
Publicado: (2023)

Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS)
por: Brucker, Sara Yvonne, et al.
Publicado: (2022)

Acute Kidney Allograft Injury Following Vitamin C Administration for Septic Shock
por: Mahling, Moritz, et al.
Publicado: (2020)

Successful long-term management of recurrent focal segmental glomerulosclerosis after kidney transplantation with costimulation blockade
por: Mühlbacher, Thomas, et al.
Publicado: (2020)

Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach
por: Guthoff, Martina, et al.
Publicado: (2015)

Minimal-invasive management of urological complications after kidney transplantation
por: Deininger, Susanne, et al.
Publicado: (2021)

No Correlation between Anti-PF4 and Anti–SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination
por: Uzun, Günalp, et al.
Publicado: (2021)

Antibody‐mediated platelet activation in COVID‐19: A coincidence or a new mechanism of the dysregulated coagulation system?
por: Althaus, Karina, et al.
Publicado: (2021)

Right Hemihepatectomy by Suprahilar Intrahepatic Transection of the Right Hemipedicle using a Vascular Stapler
por: Königsrainer, Ingmar, et al.
Publicado: (2010)

Steroid Sparing Maintenance Immunosuppression in Highly Sensitised Patients Receiving Alemtuzumab Induction
por: Santos, Eva, et al.
Publicado: (2023)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First Experience
por: Horvath, Philipp, et al.
Publicado: (2019)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Autoimmune Heparin-Induced Thrombocytopenia after Transcatheter Aortic Valve Implantation: Successful Treatment with Adjunct High-Dose Intravenous Immunoglobulin
por: Bakchoul, Tamam, et al.
Publicado: (2019)

Living donor liver transplantation with two-stage hepatectomy for patients with isolated, irresectable colorectal liver—the LIVER-T(W)O-HEAL study
por: Rauchfuß, Falk, et al.
Publicado: (2019)

Alemtuzumab induction in pediatric kidney transplantation
por: Kaabak, Michael M, et al.
Publicado: (2013)

SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020
por: Quante, Markus, et al.
Publicado: (2021)

Attitude and potential benefits of modern information and communication technology use and telemedicine in cross-sectoral solid organ transplant care
por: Holderried, Martin, et al.
Publicado: (2021)

Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
por: Zlamal, Jan, et al.
Publicado: (2023)

Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020)

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021)

Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience
por: Benazzo, Alberto, et al.
Publicado: (2019)

Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan
por: Marini, Irene, et al.
Publicado: (2019)

Urinary Tract Infections in Kidney Transplant Recipients—Is There a Need for Antibiotic Stewardship?
por: Strohaeker, Jens, et al.
Publicado: (2021)

The Prevalence and Clinical Significance of Anaerobic Bacteria in Major Liver Resection
por: Strohäker, Jens, et al.
Publicado: (2021)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets
por: Marini, Irene, et al.
Publicado: (2023)

A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma
por: Yurttas, Can, et al.
Publicado: (2021)

Vaccinations and ITP: keep on track(ing)
por: Bakchoul, Tamam, et al.
Publicado: (2022)

Living-Donor Uterus Transplantation: Pre-, Intra-, and Postoperative Parameters Relevant to Surgical Success, Pregnancy, and Obstetrics with Live Births
por: Brucker, Sara Yvonne, et al.
Publicado: (2020)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Alemtuzumab in Covid era
por: Iovino, Aniello, et al.
Publicado: (2021)

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
por: Burns, D M, et al.
Publicado: (2016)

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
por: Trindade, Anil J., et al.
Publicado: (2020)

Pregnancy following kidney transplantation - impact on mother and graft function and focus on childrens’ longitudinal development
por: Bachmann, Friederike, et al.
Publicado: (2019)

Simultaneous Islet and Kidney Transplantation in Seven Patients With Type 1 Diabetes and End-Stage Renal Disease Using a Glucocorticoid-Free Immunosuppressive Regimen With Alemtuzumab Induction
por: Tan, Jianming, et al.
Publicado: (2008)

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report
por: Bösmüller, Claudia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mkvph1agjelbflvo9jdmapt0ss